Trevanthe Medical Devices
Response requiredMedical Devices · Minneapolis, MN
May 28 – Aug 13, 2026
last 12 weeks of telemetry
Trevanthe Medical Devices is 13 points below its escalation threshold — execution bandwidth is the strongest theme at 62 against a threshold of 75. 2 escalations are open (1 elevated and 1 moderate), the oldest running 17 weeks. 1 board direction has been published, with no tracked actions against it yet.
62
Highest signal
of 75 threshold
2
Open escalations
1 elevated · 1 moderate
77%
Participation
coverage sufficient
0
Board actions
none assigned
What needs attention
3 active themesExecution Bandwidth
38 independent participants · 8 functions
Reported by 38 independent participants across 8 functions, persistent for 13 weeks and rising.Escalation open
Strategic Priority Alignment
32 independent participants · 8 functions
Reported by 32 independent participants across 8 functions, persistent for 20 weeks and rising.Escalation open
Operational Friction
27 independent participants · 8 functions
Reported by 27 independent participants across 8 functions, persistent for 9 weeks.
Escalations
2 open of 2 →Execution Bandwidth at Trevanthe Medical Devices: delivery commitments outrunning the people available to meet them
- Why it matters
- Above the escalation threshold and still building; the cost of waiting is rising each week it stays open.
- What changed
- Cross-functional corroboration from 38 distinct reporters. (9 weeks open)
- Next step
- A board direction covers this. Review tracked actions for progress.
View escalation historyHide view escalation history
Signal confidence for a execution bandwidth theme at Trevanthe Medical Devices stands at 62 against a program threshold of 75, reported independently by 38 participants across 5 functions. The pattern is consistent with a known exposure at this company — cleanroom validation gating the capacity story buyers are underwriting — which the investment thesis assumes stays contained. Signal will confirm over the coming weeks whether confidence continues to climb.
Beacon lifecycle
Crossed threshold, corroborated — board-worthy.
- May 21
Opened as Emerging
autoEscalation opened — theme first surfaced above the noise floor.
- May 28
Emerging → Developing
autoConfidence rising across consecutive weeks; coverage widened to 5 functions.
- Jun 4
Developing → Material
autoCross-functional corroboration from 38 distinct reporters.
What Signal observed
Confidence for the execution bandwidth theme reached 62 against a threshold of 75, sustained across 6 weeks with reporting from 5 distinct functions (Executive, Manufacturing, Quality, Engineering, Operations).
Strategic Priority Alignment at Trevanthe Medical Devices: stated priorities and funded priorities pulling apart
- Why it matters
- Persistent and approaching the escalation threshold — cheap to address now, expensive once it crosses.
- What changed
- Acknowledged by the Valtrix operating team; intervention under discussion. (17 weeks open)
- Next step
- A board direction covers this. Review tracked actions for progress.
View escalation historyHide view escalation history
Signal confidence for a strategic priority alignment theme at Trevanthe Medical Devices stands at 51 against a program threshold of 75, reported independently by 32 participants across 4 functions. The pattern is consistent with a known exposure at this company — quality system findings from the last audit not fully closed — which the investment thesis assumes stays contained. Signal will confirm over the coming weeks whether confidence continues to climb.
Beacon lifecycle
Building — recurring and gaining cross-functional coverage.
- Mar 26
Opened as Emerging
autoEscalation opened — theme first surfaced above the noise floor.
- Apr 2
Emerging → Developing
autoConfidence rising across consecutive weeks; coverage widened to 4 functions.
- Apr 23
Developing → Developing
manualAcknowledged by the Valtrix operating team; intervention under discussion.
What Signal observed
Confidence for the strategic priority alignment theme reached 51 against a threshold of 75, sustained across 6 weeks with reporting from 4 distinct functions (Executive, Manufacturing, Quality, Engineering).
Organizational radar
all 8 themes scored0
Escalated
3
Developing
Execution Bandwidth, Strategic Priority Alignment, Operational Friction
5
Quiet
View all eight themesHide view all eight themes
Organizational radar
Trevanthe Medical Devices across the eight themes
Every company is scored on the same eight themes, shaded against this program's own escalation threshold — so a quiet row means quiet, not unmeasured.
Confidence = unique reporters of a theme ÷ active participants over the rolling 4-week window. A cell turns red once it crosses its company's escalation threshold.
Board response
1 board direction published for Trevanthe Medical Devices, with no tracked actions assigned yet.
“Trevanthe is running two gating workstreams through one team, and the bandwidth theme is the first place that shows.”
sale preparation · held since April 2020 · Minneapolis, MN
Company contextHide company context
- Employees
- 780
- Signal seats
- 81
- 10% enrolled
- Revenue
- $212M
- EBITDA margin
- 22–25%
Investment thesis
Contract development and manufacturing for Class II devices; process planned once the second cleanroom expansion is validated.
Known exposures
- ·Cleanroom validation gating the capacity story buyers are underwriting
- ·Quality system findings from the last audit not fully closed
- ·Regulatory affairs leadership recruited nine months ago
Signal data is PE-exclusive. Portfolio company leadership has no visibility into submissions, themes, or confidence scores.
Beacon detects. Bearing interprets. You decide.